Skip to main content
Active Clinical Trials

CART-meso in Mesothelin Expressing Cancers

By April 24, 2017No Comments

Condition

Metastatic Pancreatic (Ductal) Adenocarcinoma|Epithelial Ovarian Cancer|Malignant Epithelial Pleural Mesothelioma

Estimated Enrollment: 19

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: No masking|Primary Purpose: Treatment

Study ID Numbers: UPCC31213

Study First Received: June 6, 2014

Last Updated: March 16, 2017

Estimated Primary Completion Date: November 2015

 

Primary Outcome Measures:

Number of Adverse Events

Sponsors and Collaborators:

University of Pennsylvania

Website Link: https://ClinicalTrials.gov/show/NCT02159716

Leave a Reply